Feeds

Rogue pharmacy poses as Google

Fake meds rampant

Build a business case: developing custom apps

The newest addition to the Google family has just hit the web - the search giant's very own accredited pharmacy, selling pills at rock bottom prices.

Google celebrated the launch with a brand-spanking, stylised logo - the double 'O' replaced with two blue Viagra pills.

The rogue Google pharmaceutical siteThe mail promoting the new site told us: "We've just launched a pharmaceutical interfaces for Google, as well as several new features for the people buying pills and using pharmaceutical interfaces".

Pharmaceutical interfaces, we love it. However, since we weren't entirely sure what they were, we decided to have a look.

We landed at a familiar site: but, surprise, surprise, it wasn't Google, but rogue pharmaceutical site ED Choice. ED Choice pretends to sell generic Viagra, generic Levitra, generic Cialis and other generic products that can't possibly exist, as the patents on these products have yet to expire.

Which explains why ED Choice is hiring spammers to sell its products, and why it constantly changes its server address or URL to avoid a sudden meltdown by angry hosting providers.

Rogue sites selling fake medicines are rampant these days, as NBC's Inside Dateline showed last weekend. The news show posed as an online pharmaceutical company called The Hansen Group and started trolling the web looking for suppliers of counterfeit medicines. Within weeks, companies all over the world were offering them pills of every description - from fake Viagra to Tamiflu.

Most offers were from China, which isn't surprising, as most drugs with the Viagra label sold in China are counterfeit. A Hong Kong contact even agreed to ship thousands of fake Viagra tablets every week to the Hansen Group, a deal with an estimated value of $10m.

The good news is that the people behind the operation were put behind bars before the documentary was aired.

More importantly, a ruling in a Beijing court this week could put halt to the burgeoning industry. The court overturned a 2004 decision by China's patent review board, which would have allowed local drug makers to sell legal generic versions of Viagra in China. The decision could dent the widespread availability of potentially lethal or harmful fake medicines on the net, experts say. ®

The essential guide to IT transformation

More from The Register

next story
Rupert Murdoch says Google is worse than the NSA
Mr Burns vs. The Chocolate Factory, round three!
Microsoft cries UNINSTALL in the wake of Blue Screens of Death™
Cache crash causes contained choloric calamity
Germany 'accidentally' snooped on John Kerry and Hillary Clinton
Dragnet surveillance picks up EVERYTHING, USA, m'kay?
Know what Ferguson city needs right now? It's not Anonymous doxing random people
U-turn on vow to identify killer cop after fingering wrong bloke
Snowden on NSA's MonsterMind TERROR: It may trigger cyberwar
Plus: Syria's internet going down? That was a US cock-up
Who needs hackers? 'Password1' opens a third of all biz doors
GPU-powered pen test yields more bad news about defences and passwords
e-Borders fiasco: Brits stung for £224m after US IT giant sues UK govt
Defeat to Raytheon branded 'catastrophic result'
prev story

Whitepapers

Endpoint data privacy in the cloud is easier than you think
Innovations in encryption and storage resolve issues of data privacy and key requirements for companies to look for in a solution.
Implementing global e-invoicing with guaranteed legal certainty
Explaining the role local tax compliance plays in successful supply chain management and e-business and how leading global brands are addressing this.
Top 8 considerations to enable and simplify mobility
In this whitepaper learn how to successfully add mobile capabilities simply and cost effectively.
Solving today's distributed Big Data backup challenges
Enable IT efficiency and allow a firm to access and reuse corporate information for competitive advantage, ultimately changing business outcomes.
Reg Reader Research: SaaS based Email and Office Productivity Tools
Read this Reg reader report which provides advice and guidance for SMBs towards the use of SaaS based email and Office productivity tools.